Literature DB >> 6405430

Increased paroxysmal activity of partial seizures in man by apomorphine.

M Del Zompo, F Tocco, F Marrosu, N Passino, G U Corsini.   

Abstract

In order to study the role of dopamine (DA) in the regulation of seizure mechanisms in man, a non-emetic dose of apomorphine, a direct stimulant of DA receptors, was administered to eight patients effected by different types of epilepsy. The EEG changes induced by apomorphine administration in comparison to those elicited by promazine or placebo were evaluated in a double blind cross-over study. Similarly to promazine treatment, apomorphine worsened the EEG recordings of some patients. The apomorphine-induced increase in paroxysmal activity was observed in patients affected by partial epilepsy and was not related to the sleep-inducing properties of the drug. This effect is interpreted as being the result of a stimulation of DA autoreceptors, mediating a decrease of dopaminergic activity in the central nervous system. The use of apomorphine as an EEG activating agent is suggested.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405430     DOI: 10.1007/BF00427814

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Convulsive seizures under promazine medication.

Authors:  W J BORKOWSKI; W A KOHLMEYER
Journal:  Va Med Mon (1918)       Date:  1959-04

2.  An assessment of the value of sleep-electroencephalography for the diagnosis of temporal lobe epilepsy.

Authors:  P GLOOR; C TSAI; F HADDAD
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1958-11

3.  Evidence for dopamine receptors in the human brain mediating sedation and sleep.

Authors:  G U Corsini; M Del Zompo; S Manconi; M P Piccardi; P L Onali; A Mangoni
Journal:  Life Sci       Date:  1977-05-01       Impact factor: 5.037

4.  Central monoamines and convulsine thresholds in mice and rats.

Authors:  M Kilian; H H Frey
Journal:  Neuropharmacology       Date:  1973-07       Impact factor: 5.250

5.  Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.

Authors:  W O Boggan; L S Seiden
Journal:  Physiol Behav       Date:  1971-03

6.  Neuropsychiatric implications of drugs acting on dopamine receptors: the effect of apomorphine.

Authors:  G U Corsini; F Bernardi; F Marrosu; G L Gessa
Journal:  Prog Clin Biol Res       Date:  1980

7.  Blockade of photically induced epilepsy by 'dopamine agonist' ergot alkaloids.

Authors:  G Anlezark; B Meldrum
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

8.  Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.

Authors:  A Carlsson; K Fuxe; B Hamberger; M Lindqvist
Journal:  Acta Physiol Scand       Date:  1966 Jul-Aug

9.  Schizophrenic symptoms improve with apomorphine.

Authors:  C A Tamminga; M H Schaffer; R C Smith; J M Davis
Journal:  Science       Date:  1978-05-05       Impact factor: 47.728

10.  Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.

Authors:  G U Corsini; P Onali; C Masala; C Cianchetti; A Mangoni; G Gessa
Journal:  Arch Neurol       Date:  1978-01
View more
  1 in total

1.  Comparative assessment of dopamine agonist aporphines as anticonvulsants in two models of reflex epilepsy.

Authors:  G M Anlezark; D H Blackwood; B S Meldrum; V J Ram; J L Neumeyer
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.